ClearView Wealth Limited (CVWLF)

OTCMKTS · Delayed Price · Currency is USD
0.3689
-0.0368 (-9.07%)
At close: Dec 10, 2025
Market Cap272.60M +32.5%
Revenue (ttm)303.35M +14.8%
Net Income568.30K -90.2%
EPS0.00 -90.2%
Shares Outn/a
PE Ratio479.68
Forward PE7.82
Dividendn/a
Ex-Dividend Daten/a
Volume2,000
Average Volume2,400
Open0.3686
Previous Close0.4057
Day's Range0.3686 - 0.3689
52-Week Range0.2350 - 0.4298
Beta0.28
RSIn/a
Earnings DateFeb 25, 2026

About ClearView Wealth

ClearView Wealth Limited engages in the life insurance business in Australia. It offers life insurance products, including term life, trauma and critical illness benefits, child and accident covers, accidental death income protection and business expense covers, and total permanent disability. The company also provides administration services. ClearView Wealth Limited was founded in 1976 and is headquartered in Sydney, Australia. [Read more]

Sector Financials
Founded 1976
Country Australia
Stock Exchange OTCMKTS
Ticker Symbol CVWLF

Financial Performance

Financial numbers in AUD Financial Statements

News

ClearView Wealth Limited (CVWLF) Q2 2026 Earnings Call Transcript

ClearView Wealth Limited (CVWLF) Q2 2026 Earnings Call Transcript

4 weeks ago - Seeking Alpha

Zurich Insurance to buy Australia's ClearView Wealth for $288 million

Australia's ClearView Wealth said on Tuesday that the local unit of Zurich Insurance Group has agreed to buy the life insurer for A$408.3 million ($288.30 million).

4 weeks ago - Reuters

EP Wealth Advisors Expands Presence in Phoenix Region with Acquisition of Clearview Wealth Advisors

TORRANCE, Calif.--(BUSINESS WIRE)--EP Wealth Advisors (“EP Wealth”), a leading fee-only registered investment advisor (RIA), today announced the acquisition of Clearview Wealth Advisors, LLC (“Clearvi...

3 months ago - Business Wire

ClearView Wealth Limited (CVWLF) Shareholder/Analyst Call Transcript

ClearView Wealth Limited (OTCPK:CVWLF) Shareholder/Analyst Call November 5, 2025 7:01 PM EST Company Participants Geoff Black Nadine Gooderick - MD, CEO & Executive Director Judilyn Beaumont - General...

5 months ago - Seeking Alpha